{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Some weights of BertForSequenceClassification were not initialized from the model checkpoint at bionlp/bluebert_pubmed_uncased_L-12_H-768_A-12 and are newly initialized: ['classifier.bias', 'classifier.weight']\n",
      "You should probably TRAIN this model on a down-stream task to be able to use it for predictions and inference.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "BertForSequenceClassification(\n",
      "  (bert): BertModel(\n",
      "    (embeddings): BertEmbeddings(\n",
      "      (word_embeddings): Embedding(30522, 768, padding_idx=0)\n",
      "      (position_embeddings): Embedding(512, 768)\n",
      "      (token_type_embeddings): Embedding(2, 768)\n",
      "      (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
      "      (dropout): Dropout(p=0.1, inplace=False)\n",
      "    )\n",
      "    (encoder): BertEncoder(\n",
      "      (layer): ModuleList(\n",
      "        (0-11): 12 x BertLayer(\n",
      "          (attention): BertAttention(\n",
      "            (self): BertSdpaSelfAttention(\n",
      "              (query): Linear(in_features=768, out_features=768, bias=True)\n",
      "              (key): Linear(in_features=768, out_features=768, bias=True)\n",
      "              (value): Linear(in_features=768, out_features=768, bias=True)\n",
      "              (dropout): Dropout(p=0.1, inplace=False)\n",
      "            )\n",
      "            (output): BertSelfOutput(\n",
      "              (dense): Linear(in_features=768, out_features=768, bias=True)\n",
      "              (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
      "              (dropout): Dropout(p=0.1, inplace=False)\n",
      "            )\n",
      "          )\n",
      "          (intermediate): BertIntermediate(\n",
      "            (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
      "            (intermediate_act_fn): GELUActivation()\n",
      "          )\n",
      "          (output): BertOutput(\n",
      "            (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
      "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
      "            (dropout): Dropout(p=0.1, inplace=False)\n",
      "          )\n",
      "        )\n",
      "      )\n",
      "    )\n",
      "    (pooler): BertPooler(\n",
      "      (dense): Linear(in_features=768, out_features=768, bias=True)\n",
      "      (activation): Tanh()\n",
      "    )\n",
      "  )\n",
      "  (dropout): Dropout(p=0.1, inplace=False)\n",
      "  (classifier): Linear(in_features=768, out_features=3, bias=True)\n",
      ")\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "BertForSequenceClassification(\n",
       "  (bert): BertModel(\n",
       "    (embeddings): BertEmbeddings(\n",
       "      (word_embeddings): Embedding(30522, 768, padding_idx=0)\n",
       "      (position_embeddings): Embedding(512, 768)\n",
       "      (token_type_embeddings): Embedding(2, 768)\n",
       "      (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "      (dropout): Dropout(p=0.1, inplace=False)\n",
       "    )\n",
       "    (encoder): BertEncoder(\n",
       "      (layer): ModuleList(\n",
       "        (0-11): 12 x BertLayer(\n",
       "          (attention): BertAttention(\n",
       "            (self): BertSdpaSelfAttention(\n",
       "              (query): Linear(in_features=768, out_features=768, bias=True)\n",
       "              (key): Linear(in_features=768, out_features=768, bias=True)\n",
       "              (value): Linear(in_features=768, out_features=768, bias=True)\n",
       "              (dropout): Dropout(p=0.1, inplace=False)\n",
       "            )\n",
       "            (output): BertSelfOutput(\n",
       "              (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "              (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "              (dropout): Dropout(p=0.1, inplace=False)\n",
       "            )\n",
       "          )\n",
       "          (intermediate): BertIntermediate(\n",
       "            (dense): Linear(in_features=768, out_features=3072, bias=True)\n",
       "            (intermediate_act_fn): GELUActivation()\n",
       "          )\n",
       "          (output): BertOutput(\n",
       "            (dense): Linear(in_features=3072, out_features=768, bias=True)\n",
       "            (LayerNorm): LayerNorm((768,), eps=1e-12, elementwise_affine=True)\n",
       "            (dropout): Dropout(p=0.1, inplace=False)\n",
       "          )\n",
       "        )\n",
       "      )\n",
       "    )\n",
       "    (pooler): BertPooler(\n",
       "      (dense): Linear(in_features=768, out_features=768, bias=True)\n",
       "      (activation): Tanh()\n",
       "    )\n",
       "  )\n",
       "  (dropout): Dropout(p=0.1, inplace=False)\n",
       "  (classifier): Linear(in_features=768, out_features=3, bias=True)\n",
       ")"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Load model directly\n",
    "from transformers import TrainingArguments, Trainer, AutoTokenizer, DataCollatorForLanguageModeling, AutoModelForSequenceClassification, DataCollatorWithPadding\n",
    "from datasets import load_dataset\n",
    "import pandas as pd\n",
    "import torch\n",
    "\n",
    "model = AutoModelForSequenceClassification.from_pretrained(\"bionlp/bluebert_pubmed_uncased_L-12_H-768_A-12\", num_labels=3)\n",
    "print(model)\n",
    "\n",
    "# Move model to the available device (cuda or cpu)\n",
    "device = torch.device(\"cuda\" if torch.cuda.is_available() else \"cpu\")\n",
    "# device = torch.device(\"cpu\")\n",
    "model.to(device)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Dataset({\n",
      "    features: ['pubid', 'question', 'context', 'long_answer', 'final_decision'],\n",
      "    num_rows: 100\n",
      "})\n",
      "Dataset({\n",
      "    features: ['pubid', 'question', 'context', 'long_answer', 'final_decision', 'input_ids', 'token_type_ids', 'attention_mask', 'labels'],\n",
      "    num_rows: 100\n",
      "})\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "    <div>\n",
       "      \n",
       "      <progress value='180' max='180' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
       "      [180/180 00:35, Epoch 3/3]\n",
       "    </div>\n",
       "    <table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       " <tr style=\"text-align: left;\">\n",
       "      <th>Epoch</th>\n",
       "      <th>Training Loss</th>\n",
       "      <th>Validation Loss</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>1</td>\n",
       "      <td>No log</td>\n",
       "      <td>1.445872</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2</td>\n",
       "      <td>No log</td>\n",
       "      <td>1.733259</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>3</td>\n",
       "      <td>No log</td>\n",
       "      <td>1.765103</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table><p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "\n",
       "    <div>\n",
       "      \n",
       "      <progress value='20' max='20' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
       "      [20/20 00:00]\n",
       "    </div>\n",
       "    "
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Test results: {'eval_loss': 2.2138173580169678, 'eval_runtime': 0.5662, 'eval_samples_per_second': 35.325, 'eval_steps_per_second': 35.325, 'epoch': 3.0}\n"
     ]
    }
   ],
   "source": [
    "# Get the dataset\n",
    "dataset = load_dataset(\"qiaojin/PubMedQA\", \"pqa_labeled\")\n",
    "small_dataset = dataset['train'].select(range(100))\n",
    "\n",
    "print(small_dataset)\n",
    "\n",
    "def preprocess(text):\n",
    "    questions = text['question']\n",
    "    context = text['context']\n",
    "    long_answer = text['long_answer']\n",
    "    final_decision = text['final_decision']\n",
    "\n",
    "    # Combine the question, context, and long answer\n",
    "    text = [f\"Context: {c} Question: {q}\" for c, q in zip(context, questions)]\n",
    "    token_input = tokenizer(text, return_tensors=\"pt\", padding=\"max_length\", truncation=True, max_length=512)\n",
    "\n",
    "    # Labels\n",
    "    label_mapping = {\"yes\": 0, \"no\": 1, \"maybe\": 2}\n",
    "    labels = [label_mapping[l] for l in final_decision]\n",
    "\n",
    "    # Debugging information\n",
    "    print(f\"Processed text: {text}\", len(text))\n",
    "    print(f\"Labels: {labels}\", len(labels))\n",
    "    print(f\"Tokenized input: {token_input['input_ids']}\", len(token_input['input_ids']))\n",
    "\n",
    "    # Add the labels to the token_input\n",
    "    token_input['labels'] = torch.tensor(labels, dtype=torch.long)\n",
    "\n",
    "    return token_input\n",
    "\n",
    "# Tokenize the dataset\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"bionlp/bluebert_pubmed_uncased_L-12_H-768_A-12\")\n",
    "\n",
    "tokenized_input = small_dataset.map(preprocess, batched=True)\n",
    "\n",
    "print(tokenized_input)\n",
    "\n",
    "data_collator = DataCollatorWithPadding(tokenizer=tokenizer)\n",
    "\n",
    "# Split the dataset\n",
    "train_size = 60\n",
    "validate_size = 20\n",
    "test_size = 20\n",
    "\n",
    "train_dataset, validate_dataset, test_dataset = torch.utils.data.random_split(tokenized_input, [train_size, validate_size, test_size])\n",
    "\n",
    "# Train the model\n",
    "training_args = TrainingArguments(\n",
    "    output_dir='./results',          # output directory\n",
    "    num_train_epochs=3,              # total number of training epochs\n",
    "    eval_strategy=\"epoch\",     # evaluation strategy to adopt during training\n",
    "    per_device_train_batch_size=1,  # batch size per device during training\n",
    "    per_device_eval_batch_size=1,   # batch size for evaluation\n",
    "    learning_rate=2e-5,              # learning rate\n",
    "    weight_decay=0.01,               # strength of weight decay\n",
    ")\n",
    "\n",
    "trainer = Trainer(\n",
    "    model=model,                         # the instantiated ðŸ¤— Transformers model to be trained\n",
    "    args=training_args,                  # training arguments, defined above\n",
    "    train_dataset=train_dataset,         # training dataset\n",
    "    eval_dataset=validate_dataset,        # evaluation dataset\n",
    "    data_collator=data_collator,\n",
    "    tokenizer=tokenizer\n",
    ")\n",
    "\n",
    "trainer.train()\n",
    "\n",
    "# Evaluate the model\n",
    "results = trainer.evaluate(test_dataset)\n",
    "print(\"Test results:\", results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Context: ['PRISM is claimed to score disease severity which has attributed an impact on length of PICU stay (LOS).', \"To determine the impact of PRISM on LOS, and evaluate an Artificial Neural Network's (ANN) performance to estimate LOS from PRISM item patterns.\", \"Retrospectively we performed correlation and regression analyses on routinely scored PRISM data of all consecutive admissions to our level-III PICU from 1994 to 1999 (n>2000) with individual LOS. In addition, an ANN was trained on the chronologically first 75% of those data (inputs, PRISM items + age + sex; output, LOS). The ANN's performance was tested on the remaining most recent 25% of the data sets.\", \"The Spearman and Pearson coefficients of correlation between PRISM and LOS were 0.2 (p<0.001) and 0.08 (p = 0.0003), the latter being slightly higher when LOS was logarithmically transformed. Pearson's coefficient of correlation between ANN derived LOS estimate and actual LOS was 0.21 (p<0.001) (LOS logarithmically transformed: 0.34; p<0.001) in the independent validation sample.\"]\n",
      "\n",
      "Question: Can PRISM predict length of PICU stay?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: no\n",
      "========================================================================================================================\n",
      "Context: ['Although the retroperitoneal approach has been the preferred choice for open urological procedures, retroperitoneoscopy is not the preferred approach for laparoscopy. This study aims to develop a training model for retroperitoneoscopy and to establish an experimental learning curve.', 'Fifteen piglets were operated on to develop a standard retroperitoneoscopic nephrectomy (RPN) training model. All procedures were performed with three ports. Intraoperative data (side, operative time, blood loss, peritoneal opening) were recorded. Animals were divided into groups A, the first eight, and B, the last seven cases. Data were statistically analyzed.', 'We performed fifteen RPNs. The operative time varied from 15 to 50 minutes (median 30 minutes). Blood loss varied from 5 to 100 mL (median 20 mL). We experienced five peritoneal openings; we had two surgical vascular complications managed laparoscopically. There was statistical difference between groups A and B for peritoneal opening (p = 0.025), operative time (p = 0.0037), and blood loss (p = 0.026).', 'RPN in a porcine model could simulate the whole procedure, from creating the space to nephrectomy completion. Experimental learning curve was eight cases, after statistical data analysis.']\n",
      "\n",
      "Question: Is there a model to teach and practice retroperitoneoscopic nephrectomy?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['Bystander resuscitation plays an important role in lifesaving cardiopulmonary resuscitation (CPR). A significant reduction in the \"no-flow-time\", quantitatively better chest compressions and an improved quality of ventilation can be demonstrated during CPR using supraglottic airway devices (SADs). Previous studies have demonstrated the ability of inexperienced persons to operate SADs after brief instruction. The aim of this pilot study was to determine whether an instruction manual consisting of four diagrams enables laypersons to operate a Laryngeal Mask SupremeÂ® (LMAS) in the manikin.', 'An instruction manual of four illustrations with speech bubbles displaying the correct use of the LMAS was designed. Laypersons were handed a bag containing a LMAS, a bag mask valve device (BMV), a syringe prefilled with air and the instruction sheet, and were asked to perform and ventilate the manikin as displayed. Time to ventilation was recorded and degree of success evaluated.', 'A total of 150 laypersons took part. Overall 145 participants (96.7%) inserted the LMAS in the manikin in the right direction. The device was inserted inverted or twisted in 13 (8.7%) attempts. Eight (5.3%) individuals recognized this and corrected the position. Within the first 2 minutes 119 (79.3%) applicants were able to insert the LMAS and provide tidal volumes greater than 150 ml (estimated dead space). Time to insertion and first ventilation was 83.2 Â± 29 s. No significant difference related to previous BLS training (P = 0.85), technical education (P = 0.07) or gender could be demonstrated (P = 0.25).']\n",
      "\n",
      "Question: Does a 4 diagram manual enable laypersons to operate the Laryngeal Mask SupremeÂ®?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['Synchronous liver metastases (SLM) occur in 20% of colorectal cancers (CRC). Resection of SLM and CLC can be undertaken at different centres (separate management, SM) or at the same centre (global management, GM).', 'Retrospective study of SLM and CRC resections carried out during 01/2000 - 12/2006 by SM or GM, using a combined or delayed strategy.', 'Morphologic characteristics and type of CRC and SLM resection were similar for the GM (n = 45) or SM (n = 66) groups. In patients with delayed liver resection (62 SM, 17 GM), chemotherapy prior to liver surgery was used in 92% and 38% of SM and GM patients (P<0.0001) and the median delay between procedures was 212 and 182 days, respectively (P = 0.04). First step of liver resection was more often performed during colorectal surgery in the GM group (62 vs. 6% for SM, P<0.0001) and the mean number of procedures (CRC+SLM) was lower (1.6 vs. 2.3, P = 0.003). Three-month mortality was 3% for GM and 0% for SM (n.s.). Overall survival rates were 67% and 51% for SM and GM at 3 years (n.s.), and 35 and 31% at 5 years (n.s.). Disease-free survival to 5 years was higher in SM patients (14% vs. 11%, P = 0.009).']\n",
      "\n",
      "Question: Colorectal cancer with synchronous liver metastases: does global management at the same centre improve results?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: no\n",
      "========================================================================================================================\n",
      "Context: ['Apparent life-threatening events in infants are a difficult and frequent problem in pediatric practice. The prognosis is uncertain because of risk of sudden infant death syndrome.', 'Eight infants aged 2 to 15 months were admitted during a period of 6 years; they suffered from similar maladies in the bath: on immersion, they became pale, hypotonic, still and unreactive; recovery took a few seconds after withdrawal from the bath and stimulation. Two diagnoses were initially considered: seizure or gastroesophageal reflux but this was doubtful. The hypothesis of an equivalent of aquagenic urticaria was then considered; as for patients with this disease, each infant\\'s family contained members suffering from dermographism, maladies or eruption after exposure to water or sun. All six infants had dermographism. We found an increase in blood histamine levels after a trial bath in the two infants tested. The evolution of these \"aquagenic maladies\" was favourable after a few weeks without baths. After a 2-7 year follow-up, three out of seven infants continue to suffer from troubles associated with sun or water.']\n",
      "\n",
      "Question: Syncope during bathing in infants, a pediatric form of water-induced urticaria?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['Programmed cell death (PCD) is the regulated death of cells within an organism. The lace plant (Aponogeton madagascariensis) produces perforations in its leaves through PCD. The leaves of the plant consist of a latticework of longitudinal and transverse veins enclosing areoles. PCD occurs in the cells at the center of these areoles and progresses outwards, stopping approximately five cells from the vasculature. The role of mitochondria during PCD has been recognized in animals; however, it has been less studied during PCD in plants.', 'The following paper elucidates the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis. A single areole within a window stage leaf (PCD is occurring) was divided into three areas based on the progression of PCD; cells that will not undergo PCD (NPCD), cells in early stages of PCD (EPCD), and cells in late stages of PCD (LPCD). Window stage leaves were stained with the mitochondrial dye MitoTracker Red CMXRos and examined. Mitochondrial dynamics were delineated into four categories (M1-M4) based on characteristics including distribution, motility, and membrane potential (Î”Î¨m). A TUNEL assay showed fragmented nDNA in a gradient over these mitochondrial stages. Chloroplasts and transvacuolar strands were also examined using live cell imaging. The possible importance of mitochondrial permeability transition pore (PTP) formation during PCD was indirectly examined via in vivo cyclosporine A (CsA) treatment. This treatment resulted in lace plant leaves with a significantly lower number of perforations compared to controls, and that displayed mitochondrial dynamics similar to that of non-PCD cells.']\n",
      "\n",
      "Question: Do mitochondria play a role in remodelling lace plant leaves during programmed cell death?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['The endogenous estradiol metabolite, 2-methoxyestradiol (2ME), has been shown to be a potent inhibitor of cell growth and a strong anti-angiogenic substance. We investigated for the first time whether in vitro combinations of 2ME with various chemotherapeutic compounds may result in an additive inhibitory effect on the proliferation of human ovary cancer cells.', 'As a model two different human ovary cancer cell lines were used. All cell lines were incubated with equimolar concentrations of 2ME (0.8-25 microM) and the chemotherapeutics epirubicine, doxorubicine, paclitaxel, docetaxel, carboplatin, vinorelbine, 5-fluorouracil and mafosfamide. Proliferation was measured after four days using the ATP-chemosensitivity test.', 'For both ovary cancer cell lines a significant additive effect of 2ME with epirubicine and carboplatin was observed at the lower concentration range of these chemotherapeutic substances.']\n",
      "\n",
      "Question: Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['To evaluate the impact of HER2 immunoreactivity on clinical outcome in locally advanced urothelial carcinoma patients who received surgery alone, or methotrexate, vinblastine, epirubicin, and cisplatin (M-VEC) as adjuvant chemotherapy.', \"We studied 114 formalin-fixed paraffin-embedded specimens obtained from locally advanced urothelial carcinoma patients receiving surgery alone or adjuvant M-VEC. The authors evaluated HER2 immunoreactivity using immunohistochemical staining and explored the influence of pathological parameters and HER2 immunoreactivity on progression-free survival (PFS) and disease-specific overall survival (OS) using univariate and multivariate Cox's analyses.\", 'Urothelial carcinoma of the bladder had a significantly higher frequency of HER2 immunoreactivity than that of the upper urinary tract (60.7 vs. 20.7%, p<0.0001). Overall, nodal status was a strong and independent prognostic indicator for clinical outcome. The HER2 immunoreactivity was significantly associated with PFS (p = 0.02) and disease-specific OS (p = 0.005) in advanced urothelial carcinoma patients. As for patients with adjuvant M-VEC, HER2 immunoreactivity was a significant prognostic factor for PFS (p = 0.03) and disease-specific OS (p = 0.02) using univariate analysis, but not multivariate analysis, and not for patients receiving watchful waiting.']\n",
      "\n",
      "Question: Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: maybe\n",
      "========================================================================================================================\n",
      "Context: ['Trauma patients who require therapeutic anticoagulation pose a difficult treatment problem. The purpose of this study was to determine: (1) the incidence of complications using therapeutic anticoagulation in trauma patients, and (2) if any patient factors are associated with these complications.', 'An 18-month retrospective review was performed on trauma patients>or= 15 years old who received therapeutic anticoagulation using unfractionated heparin (UH) and/or fractionated heparin (FH). Forty different pre-treatment and treatment patient characteristics were recorded. Complications of anticoagulation were documented and defined as any unanticipated discontinuation of the anticoagulant for bleeding or other adverse events.', 'One-hundred-fourteen trauma patients were initiated on therapeutic anticoagulation. The most common indication for anticoagulation was deep venous thrombosis (46%). Twenty-four patients (21%) had at least 1 anticoagulation complication. The most common complication was a sudden drop in hemoglobin concentration requiring blood transfusion (11 patients). Five patients died (4%), 3 of whom had significant hemorrhage attributed to anticoagulation. Bivariate followed by logistic regression analysis identified chronic obstructive pulmonary disease (OR = 9.2, 95%CI = 1.5-54.7), UH use (OR = 3.8, 95%CI = 1.1-13.0), and lower initial platelet count (OR = 1.004, 95%CI = 1.000-1.008) as being associated with complications. Patients receiving UH vs. FH differed in several characteristics including laboratory values and anticoagulation indications.']\n",
      "\n",
      "Question: Therapeutic anticoagulation in the trauma patient: is it safe?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: no\n",
      "========================================================================================================================\n",
      "Context: ['From March 2007 to January 2011, 88 DBE procedures were performed on 66 patients. Indications included evaluation anemia/gastrointestinal bleed, small bowel IBD and dilation of strictures. Video-capsule endoscopy (VCE) was used prior to DBE in 43 of the 66 patients prior to DBE evaluation.', \"The mean age was 62 years. Thirty-two patients were female, 15 were African-American; 44 antegrade and 44 retrograde DBEs were performed. The mean time per antegrade DBE was 107.4Â±30.0 minutes with a distance of 318.4Â±152.9 cm reached past the pylorus. The mean time per lower DBE was 100.7Â±27.3 minutes with 168.9Â±109.1 cm meters past the ileocecal valve reached. Endoscopic therapy in the form of electrocautery to ablate bleeding sources was performed in 20 patients (30.3%), biopsy in 17 patients (25.8%) and dilation of Crohn's-related small bowel strictures in 4 (6.1%). 43 VCEs with pathology noted were performed prior to DBE, with findings endoscopically confirmed in 32 cases (74.4%). In 3 cases the DBE showed findings not noted on VCE.\"]\n",
      "\n",
      "Question: Double balloon enteroscopy: is it efficacious and safe in a community setting?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['Treatment of neonatal testicular torsion has two objectives: salvage of the involved testicle (which is rarely achieved) and preservation of the contralateral gonad. The second goal universally involves contralateral testicular scrotal fixation to prevent the future occurrence of contralateral torsion. However, there is controversy with regards to management of a synchronous contralateral hydrocele. It has been our policy not to address the contralateral hydrocele through an inguinal incision to minimize potential injury to the spermatic cord. Our objective in this study was to determine whether the decision to manage a contralateral hydrocele in cases of neonatal testicular torsion solely through a scrotal approach is safe and effective.', 'We reviewed all cases of neonatal testicular torsion occurring at our institution between the years 1999 and 2006. Age at presentation, physical examination, ultrasonographic and intraoperative findings were recorded. Patients were followed after initial surgical intervention to determine the likelihood of developing a subsequent hydrocele or hernia.', 'Thirty-seven patients were identified as presenting with neonatal torsion. Age of presentation averaged 3.5 days (range 1-14 days). Left-sided pathology was seen more commonly than the right, with a 25:12 distribution. All torsed testicles were nonviable. Twenty-two patients were noted to have a contralateral hydrocele at presentation. All hydroceles were opened through a scrotal approach at the time of contralateral scrotal fixation. No patient underwent an inguinal exploration to examine for a patent process vaginalis. None of the patients who presented with a hydrocele have developed a clinical hydrocele or hernia after an average 7.5 years (range 4.3-11.2) follow-up.']\n",
      "\n",
      "Question: Treatment of contralateral hydrocele in neonatal testicular torsion: Is less more?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: maybe\n",
      "========================================================================================================================\n",
      "Context: ['For women, the correlation between circulating androgens and sexual desire is inconclusive. Substitution with androgens at physiological levels improves sexual function in women who experience decreased sexual desire and androgen deficiency from surgical menopause, pituitary disease, and age-related decline in androgen production in the ovaries. Measuring bioactive testosterone is difficult and new methods have been proposed, including measuring the primary androgen metabolite androsterone glucuronide (ADT-G).AIM: The aim of this study was to investigate a possible correlation between serum levels of androgens and sexual desire in women and whether the level of ADT-G is better correlated than the level of circulating androgens with sexual desire.', 'This was a cross-sectional study including 560 healthy women aged 19-65 years divided into three age groups. Correlations were considered to be statistically significant at P<0.05.', 'Sexual desire was determined as the total score of the sexual desire domain of the Female Sexual Function Index. Total testosterone (TT), calculated free testosterone (FT), androstenedione, dehydroepiandrosterone sulfate (DHEAS), and ADT-G were analyzed using mass spectrometry.', 'Sexual desire correlated overall with FT and androstenedione in the total cohort of women. In a subgroup of women aged 25-44 years with no use of systemic hormonal contraception, sexual desire correlated with TT, FT, androstenedione, and DHEAS. In women aged 45-65 years, androstenedione correlated with sexual desire. No correlations between ADT-G and sexual desire were identified.']\n",
      "\n",
      "Question: Is there a correlation between androgens and sexual desire in women?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['One of the problems with manual resuscitators is the difficulty in achieving accurate volume delivery. The volume delivered to the patient varies by the physical characteristics of the person and method. This study was designed to compare tidal volumes delivered by the squeezing method, physical characteristics and education and practice levels.', '114 individuals trained in basic life support and bag-valve-mask ventilation participated in this study. Individual characteristics were obtained by the observer and the education and practice level were described by the subjects. Ventilation was delivered with a manual resuscitator connected to a microspirometer and volumes were measured. Subjects completed three procedures: one-handed, two-handed and two-handed half-compression.', 'The mean (standard deviation) volumes for the one-handed method were 592.84 ml (SD 117.39), two-handed 644.24 ml (SD 144.7) and two-handed half-compression 458.31 ml (SD 120.91) (p<0.01). Tidal volume delivered by two hands was significantly greater than that delivered by one hand (r = 0.398, p<0.01). The physical aspects including hand size, volume and grip power had no correlation with the volume delivered. There were slight increases in tidal volume with education and practice, but correlation was weak (r = 0.213, r = 0.281, r = 0.131, p<0.01).']\n",
      "\n",
      "Question: Can you deliver accurate tidal volume by manual resuscitator?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: no\n",
      "========================================================================================================================\n",
      "Context: ['To assess and compare the value of split-liver transplantation (SLT) and living-related liver transplantation (LRT).', 'The concept of SLT results from the development of reduced-size transplantation. A further development of SLT, the in situ split technique, is derived from LRT, which itself marks the optimized outcome in terms of postoperative graft function and survival. The combination of SLT and LRT has abolished deaths on the waiting list, thus raising the question whether living donor liver transplantation is still necessary.', 'Outcomes and postoperative liver function of 43 primary LRT patients were compared with those of 49 primary SLT patients (14 ex situ, 35 in situ) with known graft weight performed between April 1996 and December 2000. Survival rates were analyzed using the Kaplan-Meier method.', 'After a median follow-up of 35 months, actual patient survival rates were 82% in the SLT group and 88% in the LRT group. Actual graft survival rates were 76% and 81%, respectively. The incidence of primary nonfunction was 12% in the SLT group and 2.3% in the LRT group. Liver function parameters (prothrombin time, factor V, bilirubin clearance) and surgical complication rates did not differ significantly. In the SLT group, mean cold ischemic time was longer than in the LRT group. Serum values of alanine aminotransferase during the first postoperative week were significantly higher in the SLT group. In the LRT group, there were more grafts with signs of fatty degeneration than in the SLT group.']\n",
      "\n",
      "Question: Is there still a need for living-related liver transplantation in children?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['Deaths from injury and poisoning (suicide, accidents, undetermined deaths, and homicide) are the major cause of death among young men aged 15-39 years in England and Wales and have been increasing in recent years.AIM: To describe common characteristics among young men who die from injury and poisoning.', \"We employed a retrospective survey methodology to investigate factors associated with deaths by injury and poisoning among young men aged 15-39 years (n = 268) in Merseyside and Cheshire during 1995. Data were collected from Coroner's inquest notes and General Practitioner records.\", 'The most common cause of death was poisoning by alcohol and drugs (29.1%, n = 78). A high proportion of cases were unemployed (39.4%, n = 106). Cases were also more likely to be single compared to the general population (74.2% vs 55.5%). Self-destructive behaviour was evident in 77% of deaths (n = 206).']\n",
      "\n",
      "Question: Injury and poisoning mortality among young men--are there any common factors amenable to prevention?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['The accepted treatment protocol for necrotizing fasciitis (NF) consists of extensive surgery and wide spectrum antibiotics. Hyperbaric oxygenation (HBO) has been recommended as adjuvant therapy for NF, improving patient mortality and outcome. However, the beneficial effect of HBO for NF remains controversial.', 'A retrospective evaluation of treatment outcome in 37 patients treated for NF between 1984 and 1993 was carried out. The mortality rate, morbidity criteria, and risk factors for grave prognosis were compared between a group of 25 patients who received HBO as part of their treatment protocol and a group of the remaining 12 patients treated by surgical excision and antibiotics alone.', \"The two groups were found to be similar with regard to age, gender, the incidence of individual risk factors for ominous prognosis, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score for disease's severity on presentation. The mortality rate among the HBO-treated patients was 36%, as opposed to 25% in the non-HBO group. The mean number of surgical dÃ©bridements required per patient was significantly higher in the HBO group: 3.3 compared with 1.5 in the non-HBO-treated patients. Although the average length of hospitalization for survivors was shorter for the HBO group, the difference between the groups did not reach statistical significance.\"]\n",
      "\n",
      "Question: Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: no\n",
      "========================================================================================================================\n",
      "Context: ['The morbidity and mortality associated with Panton-Valentine leucocidin (PVL)-positive Staphylococcus aureus suggest that this toxin is a key marker of disease severity. Nevertheless, the importance of PVL in the pathogenesis of primary bacteraemia caused by S. aureus is uncertain. We have determined the prevalence of PVL-encoding genes among isolates of S. aureus from bacteraemic patients.', 'Consecutive bacteraemia isolates of S. aureus (n=244) from patients hospitalized in 25 centres in the UK and Ireland during 2005 were screened for PVL and mecA genes. PVL-positive isolates were characterized by toxin gene profiling, PFGE, spa-typing and MIC determinations for a range of antimicrobials.', 'Four out of 244 isolates (1.6%) were PVL-positive and susceptible to oxacillin [methicillin-susceptible S. aureus (MSSA)]. Eighty-eight out of 244 (36%) were oxacillin-resistant (methicillin-resistant S. aureus), but none was PVL-positive. The four patients (two males: 30 and 33 years; two females: 62 and 80 years) had infection foci of: skin and soft tissue, unknown, indwelling line, and surgical site, and were located at one centre in Wales, one in England and two in Ireland. One of four PVL-positive isolates was resistant to penicillin and fusidic acid, the remainder were susceptible to all antibiotics tested. Genotypic analyses showed that the four isolates represented three distinct strains; the two isolates from Ireland were related.']\n",
      "\n",
      "Question: Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: maybe\n",
      "========================================================================================================================\n",
      "Context: ['Assessment of visual acuity depends on the optotypes used for measurement. The ability to recognize different optotypes differs even if their critical details appear under the same visual angle. Since optotypes are evaluated on individuals with good visual acuity and without eye disorders, differences in the lower visual acuity range cannot be excluded. In this study, visual acuity measured with the Snellen E was compared to the Landolt C acuity.', '100 patients (age 8 - 90 years, median 60.5 years) with various eye disorders, among them 39 with amblyopia due to strabismus, and 13 healthy volunteers were tested. Charts with the Snellen E and the Landolt C (Precision Vision) which mimic the ETDRS charts were used to assess visual acuity. Three out of 5 optotypes per line had to be correctly identified, while wrong answers were monitored. In the group of patients, the eyes with the lower visual acuity, and the right eyes of the healthy subjects, were evaluated.', 'Differences between Landolt C acuity (LR) and Snellen E acuity (SE) were small. The mean decimal values for LR and SE were 0.25 and 0.29 in the entire group and 0.14 and 0.16 for the eyes with strabismus amblyopia. The mean difference between LR and SE was 0.55 lines in the entire group and 0.55 lines for the eyes with strabismus amblyopia, with higher values of SE in both groups. The results of the other groups were similar with only small differences between LR and SE.']\n",
      "\n",
      "Question: Landolt C and snellen e acuity: differences in strabismus amblyopia?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: no\n",
      "========================================================================================================================\n",
      "Context: [\"To determine the impact of Florida's Medicaid Demonstration 4 years post-implementation on per member per month (PMPM) Medicaid expenditures and whether receiving care through HMOs versus provider service networks (PSNs) in the Demonstration was associated with PMPM expenditures.DATA: Florida Medicaid claims from two fiscal years prior to implementation of the Demonstration (FY0405, FY0506) and the first four fiscal years after implementation (FY0607-FY0910) from two urban Demonstration counties and two urban non-Demonstration counties.\", 'A difference-in-difference approach was used to compare changes in enrollee expenditures before and after implementation of the Demonstration overall and specifically for HMOs and PSNs.', 'Claims data were extracted for enrollees in the Demonstration and non-Demonstration counties and collapsed into monthly amounts (N = 26,819,987 person-months).', 'Among SSI enrollees, the Demonstration resulted in lower increases in PMPM expenditures over time ($40) compared with the non-Demonstration counties ($186), with Demonstration PSNs lowering PMPM expenditures by $7 more than HMOs. Savings were also seen among TANF enrollees but to a lesser extent.']\n",
      "\n",
      "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: yes\n",
      "========================================================================================================================\n",
      "Context: ['The records of 465 patients with an established diagnosis of age related macular degeneration who had attended a specialist macular clinic between 1990 and 1998 were scrutinised. A full clinical examination and standardised refraction had been carried out in 189 of these cases on a minimum of two occasions. Cases were looked for where an improvement of one or more lines of either distance or near acuity was recorded in the eye unaffected by macular disease. In each one of these cases the improvement in visual acuity could not be attributed to treatment of other existing pathology.', '12 such cases were detected. In nine of these the eye showing improvement of acuity had a history of amblyopia. The mean improvement in distance and near acuity in amblyopic eyes by 12 months was 3.3 and 1.9 lines logMAR respectively. The improvement in acuity generally occurred between 1 and 12 months from baseline and remained stable over the period of follow up.']\n",
      "\n",
      "Question: Amblyopia: is visual loss permanent?\n",
      "\n",
      "Predicted answer: yes\n",
      "\n",
      "Actual answer: no\n",
      "========================================================================================================================\n",
      "Accuracy: 0.5\n"
     ]
    }
   ],
   "source": [
    "def predict_answer(context, question):\n",
    "    text = f\"Context: {context['contexts']} Question: {question}\"\n",
    "    token_input = tokenizer(text, return_tensors=\"pt\", padding=\"max_length\", truncation=True, max_length=512).to(device)\n",
    "\n",
    "    # Generate model output (logits)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(**token_input)\n",
    "\n",
    "    # Extract the logits from the model output\n",
    "    logits = outputs.logits\n",
    "\n",
    "    # Get the predicted class (use argmax to get the index of the highest score)\n",
    "    predicted_class = torch.argmax(logits, dim=-1).item()\n",
    "\n",
    "    # Map the index to the label\n",
    "    label_mapping = {0: \"yes\", 1: \"no\", 2: \"maybe\"}\n",
    "    prediction = label_mapping[predicted_class]\n",
    "\n",
    "    return prediction\n",
    "\n",
    "count = 0\n",
    "for example in test_dataset:\n",
    "    context = example['context']\n",
    "    question = example['question']\n",
    "    answer = example['final_decision']\n",
    "    prediction = predict_answer(context, question)\n",
    "\n",
    "    print(f\"Context: {context['contexts']}\")\n",
    "    print()\n",
    "    print(f\"Question: {question}\")\n",
    "    print()\n",
    "    print(f\"Predicted answer: {prediction}\")\n",
    "    print()\n",
    "    print(f\"Actual answer: {answer}\")\n",
    "    print(\"=\"*120)\n",
    "\n",
    "    if prediction == answer:\n",
    "        count += 1\n",
    "\n",
    "print(f\"Accuracy: {count/len(test_dataset)}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
